Drug Regulation

Cannabis Legalization Synthetic Opioids Patent Rights Cannabis Legislation Psychedelic Substances Psychedelics Clinical Research Legal Standards Access to Medications Generic Drug Use

10 ARTICLES

3mo ago

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

The court said routine FDA-compliant labels and ordinary marketing do not by themselves prove inducement and set a higher bar requiring clear affirmative steps to encourage patented uses.

3 ARTICLES

last yr.

Canadian Cannabis Potency Surge Tied to Rising Psychosis and Schizophrenia Risks